Clinical Trials
2 trialsNCT04620603 2026-05-05
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer
Case Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT05479812 2026-02-09
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
Werewolf Therapeutics, Inc.
Phase 1 Active not recruiting